North America Leads Chemotherapy at Home Services Market, Driven by Increasing Cancer Incidence and Provider Expansion


Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Chemotherapy At Home Services Market Size, Share & Trends Analysis Report By Product (Oral, Infusion), By Cancer Type (Leukemia, Lung Cancer, Breast Cancer, Colon Cancer, Rectum Cancer), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global chemotherapy at home services market size is expected to reach USD 2.63 billion by 2030. It is projected to register a CAGR of 8.28% during the forecast period.

The market's growth can be attributed to the increasing shift of patients from hospital to home care settings. Moreover, the lower cost of services compared to hospital settings is expected to boost the demand for the market.

Cancer patients have rapidly adopted technologically advanced or improved chemotherapy devices and telemedicine to benefit from treatment at remote locations with patient safety and convenience. This is expected to boost the growth of the market over the forecast period. Many portable devices have been launched recently to improve the administration of chemotherapy drugs, contributing to the market's growth. For instance, in March 2022, Shanghai MicroPort Lifesciences Co., Ltd. received marketing approval for "AutoEx Chemotherapy Infusion Pump" from the National Medical Products Administration (NMPA) of China.

The COVID-19 pandemic positively impacted the market owing to increased demand and physicians' promotion of chemotherapy at home services. Moreover, due to the shortage of beds in the hospital settings, companies were focusing on transitioning patients from the hospital to in-home, creating demand for the services. Hence, many service providers launched services to cater to the growing demand for chemotherapy post-pandemic. For instance, in September 2022, Jivika Healthcare launched the ChemoAtHome service in Mumbai to provide access to affordable and high-quality cancer care services to patients.

Companies Mentioned

  • Sciensus Pharma Services Limited
  • Portea Medical
  • Ubiqare
  • Penn Medicine (The Trustees of the University of Pennsylvania)
  • Advocate Health Care
  • View Health Pty Ltd group (chemo@home Pty Ltd)
  • Vitalis Health and Home Care Pty Ltd
  • Medibank Private Limited
  • TCP Homecare
  • LloydsPharmacy Clinical Homecare

Chemotherapy At Home Services Report Highlights

  • Based on the product, the oral segment held the largest market share in 2022 owing to the lower cost of the products and the availability of reimbursement for such products in the market
  • Based on the cancer type, leukemia dominated the market in 2022, as chemotherapy is considered one of the primary treatment methods for leukemia patients. The high share of the segment can be due to the high preference for home-based chemotherapy by leukemia patients
  • Based on the region, the North America region held the largest market share in 2022 owing to the growing incidence of cancer in the region, and the rising number of providers offering chemotherapy at home services
  • The market is highly fragmented, with the presence of small-scale businesses offering home-based chemotherapy services. Many companies in developing countries are partnering with cancer treatment centers to offer at home cancer treatment services

Key Attributes:

Report AttributeDetails
No. of Pages168
Forecast Period2022 - 2030
Estimated Market Value (USD) in 2022$1.39 Billion
Forecasted Market Value (USD) by 2030$2.63 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Dynamics
3.1.1. Market Driver Analysis
3.1.1.1. Increasing incidence of cancer
3.1.1.2. Lower cost of home-based chemotherapy services compared to hospital based services
3.1.1.3. Increasing technological advancements and government initiatives
3.1.2. Market Restraint Analysis
3.1.2.1. Lower reimbursement for chemotherapy at home services
3.1.2.2. Lack of skilled medical staff
3.2. Industry Analysis Tools
3.2.1. Porter's Five Forces Analysis
3.2.2. PESTLE Analysis
3.3. COVID-19 Impact Analysis

Chapter 4. Chemotherapy At Home Services Market: Product Estimates & Trend Analysis

Chapter 5. Chemotherapy At Home Services Market: Cancer Type Estimates & Trend Analysis

Chapter 6. Chemotherapy At Home Services Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

Chapter 8. Recommendations/Key Market Insights

For more information about this report visit https://www.researchandmarkets.com/r/clmarw

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Global Chemotherapy At Home Services Market

Contact Data